期刊文献+

Mechanism of over-activation in direct pathway mediated by dopamine D_1 receptor in rats with levodopa-induced dyskinesias 被引量:9

Mechanism of over-activation in direct pathway mediated by dopamine D_1 receptor in rats with levodopa-induced dyskinesias
下载PDF
导出
摘要 Objective To study the changes of prodynorphin (PDyn) gene expression and dopamine and cAMPregulated phosphoprotein of 32 kDa (DARPP-32) phosphorylation in rats with levodopa-induced dyskinesias (LID), and to explore the mechanism of over-activation in direct pathway mediated by dopamine D1 receptor. Methods Parkinson's disease (PD) rats were received levodopa (10 mg/kg, i.p.) for 28 d to get the LID rats. According to the behavior scale, LID rats were divided into mild (n=8) and severe (n=16) groups. On day 29, 8 rats in severe LID group were given an acute intraperitoneal injection of MK-801 (0.1 mg/kg) 15 min before levodopa treatment (MK-801 group, n=8). The normal rats received same course and dosage of levodopa as the control group (n=8). Hybridization in situ was used to measure the expression of PDyn mRNA in striatum. Protein and mRNA levels of total DARPP-32 and phospho-Thr-34 DARPP-32 level were measured by immunoblotting and RT-PCR, respectively. Results The levels of PDyn mRNA and phospho-Thr-34 DARPP-32 increased significantly in LID rats compared with control rats (P〈0.01), and they also increased markedly in severe LID group compared with mild group (P〈0.01). Conclusion Phospho-Thr-34 DARPP-32 level was increased in LID rats, which contributed to the over-activation of direct pathway mediated by dopamine D1 receptor. Objective To study the changes of prodynorphin (PDyn) gene expression and dopamine and cAMPregulated phosphoprotein of 32 kDa (DARPP-32) phosphorylation in rats with levodopa-induced dyskinesias (LID), and to explore the mechanism of over-activation in direct pathway mediated by dopamine D1 receptor. Methods Parkinson's disease (PD) rats were received levodopa (10 mg/kg, i.p.) for 28 d to get the LID rats. According to the behavior scale, LID rats were divided into mild (n=8) and severe (n=16) groups. On day 29, 8 rats in severe LID group were given an acute intraperitoneal injection of MK-801 (0.1 mg/kg) 15 min before levodopa treatment (MK-801 group, n=8). The normal rats received same course and dosage of levodopa as the control group (n=8). Hybridization in situ was used to measure the expression of PDyn mRNA in striatum. Protein and mRNA levels of total DARPP-32 and phospho-Thr-34 DARPP-32 level were measured by immunoblotting and RT-PCR, respectively. Results The levels of PDyn mRNA and phospho-Thr-34 DARPP-32 increased significantly in LID rats compared with control rats (P〈0.01), and they also increased markedly in severe LID group compared with mild group (P〈0.01). Conclusion Phospho-Thr-34 DARPP-32 level was increased in LID rats, which contributed to the over-activation of direct pathway mediated by dopamine D1 receptor.
出处 《Neuroscience Bulletin》 SCIE CAS CSCD 2006年第3期159-164,共6页 神经科学通报(英文版)
关键词 levodopa-induced dyskinesias PRODYNORPHIN Dopamine and cAMP-regulated phosphoprotein of 32 kDa levodopa-induced dyskinesias Prodynorphin Dopamine and cAMP-regulated phosphoprotein of 32 kDa
  • 相关文献

参考文献2

二级参考文献27

  • 1Henry B,Crossman AR,Brotchie JM.Effect of repeated L-dopa,bromocriptine,or lisuide administration on preproenkephalin-A andpreproenkephalin-B mRNA levels in the striatum of the 6 hydroxydopamine-lesioned rat [ J ].Exp Neurol,1999,155(2):204-220.
  • 2Van De Witte SV,Groenewegen HJ,Voorn P.MK801 alters the effects of priming with L-dopa on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons[J].Synapse,2002,43(1):1-11.
  • 3Quik M,Police S,Langston JW,et al.Increases in striatal preproenkephalin gene expression are associated with nigrostriatal damage but not L-DOPA-induced dyskinesias in the sqirrel monkey [ J ].Neuroscience,2002,113(1):213-220.
  • 4Bibb JA,Chen JS,Taylor JR,et al.Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5 [ J ].Nature,2001,410(6826):376-379.
  • 5Oh JD,Vaughan CL,Chase TN.Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits[ J].Brain Res,1999,821(1-2):433-442.
  • 6Lee CS,Cenci MA,Schulzer M,et al.Embryonic ventral mesen cephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson disease [ J ].Brain,2000,123(7):1365-1379.
  • 7Li YS,HayakawaK,HardyRR.The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver[J].J Exp Med,1993,178(3):951-960.
  • 8Ida J,Llewellyn-Smith I J,Pivowsky P,et al.Retrograde tracers for light and electron microscopy[ M].In:Bolam JP eds.Experimental neuroanatomy:A practical approach.New York:Oxford U niversity Press,1992.31-59.
  • 9Henry B,Fox SH,Crossman AR,et al.μ-and δ-opioid receptor antagonists reduced levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson disease[ J].Exp Neurol,2001,171(1):139-146.
  • 10Nestler EJ,Kelz MB,Chen JS.ΔFosB:a molecular mediator of long-term neural and behavioral plasiticity[ J ].Brain Res,1999,835(1):10-17.

共引文献19

同被引文献32

引证文献9

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部